Efficacy and clinical relevance of vilazodone in the treatment of major depressive disorder: a pooled analysis of phase III clinical trials

被引：0
|
作者：
Khan, A. [1 ]
Song, W. [2 ]
Edwards, J. [2 ]
Ruth, A. [3 ]
机构：
[1] Northwest Clin Res Ctr, Belleview, FL USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Prescott Med Commun Grp, Chicago, IL USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70379-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S253 / S254
页数：2
相关论文
共 50 条
  • [31] Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
    Zhang, Xiao-Fei
    Wu, Lei
    Wan, Dong-Jun
    Liu, Ruo-Zhuo
    Dong, Zhao
    Chen, Min
    Yu, Sheng-Yuan
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1957 - 1965
  • [32] A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder
    Sinha, Shubhadeep
    Chary, Sreenivasa
    Thakur, Pankaj
    Talluri, Leela
    Reddy, Mohan
    Verma, Kamal K.
    Saha, Pradeep
    Gupta, Vijaya B.
    Ramaiah, Kaja A.
    Khanum, Siquafa Z.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [33] Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials
    Hudson, JI
    Wohlreich, MM
    Kajdasz, DK
    Mallinckrodt, CH
    Watkin, JG
    Martynov, OV
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (05) : 327 - 341
  • [34] Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial
    Clayton, Anita H.
    Gommoll, Carl
    Chen, Dalei
    Nunez, Rene
    Mathews, Maju
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (04) : 216 - 223
  • [35] Bupropion suicidality analysis in adult major depressive disorder clinical trials
    Wightman, Donna S.
    Harriett, April E.
    Richard, Nathalie E.
    Horrigan, Joseph P.
    Modell, Jack G.
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 19 (02) : 225 - 225
  • [36] Duloxetine: clinical efficacy, safety and tolerability in treatment of major depressive disorder
    Tarolla, E.
    Brugnoli, R.
    Pancheri, P.
    [J]. JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2007, 13 (02): : 258 - 278
  • [37] Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trials
    Jain, Rakesh
    Chen, Dalei
    Edwards, John
    Mathews, Maju
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (02) : 263 - 270
  • [38] A Pooled Analysis of the Efficacy of Desvenlafaxine for the Treatment of Major Depressive Disorder in Perimenopausal and Postmenopausal Women
    Kornstein, Susan G.
    Clayton, Anita H.
    Bao, Weihang
    Guico-Pabia, Christine J.
    [J]. JOURNAL OF WOMENS HEALTH, 2015, 24 (04) : 281 - 290
  • [39] Medical conditions in fibromyalgia patients and their relationship to pregabalin efficacy: pooled analysis of Phase III clinical trials
    Bhadra, Pritha
    Petersel, Danielle
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (17) : 2805 - 2812
  • [40] Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment
    Minelli, A.
    [J]. EUROPEAN PSYCHIATRY, 2022, 65 : S39 - S40
12345